内分泌科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 内分泌科威廉亚洲博彩公司

中国糖尿病肾脏病防治威廉亚洲博彩公司 (2021年版)

2021-07-20 中华医学会糖尿病学分会 国际内分泌代谢杂志. 2021,41(04)

糖尿病肾脏病

近年来,国内外糖尿病肾脏病（DKD）的研究取得了许多重要进展,获得了更多循证医学证据。中华医学会糖尿病学分会微血管并发症学组组织全国内分泌及肾脏病领域相关专家编写了该威廉亚洲博彩公司 ,旨在传递最新及重要进展,进一

中文标题：

中国糖尿病肾脏病防治威廉亚洲博彩公司 (2021年版)

发布机构：

中华医学会糖尿病学分会

发布日期：

2021-07-20

简要介绍：

近年来,国内外糖尿病肾脏病（DKD）的研究取得了许多重要进展,获得了更多循证医学证据。中华医学会糖尿病学分会微血管并发症学组组织全国内分泌及肾脏病领域相关专家编写了该威廉亚洲博彩公司 ,旨在传递最新及重要进展,进一步规范DKD的管理。威廉亚洲博彩公司 内容涵盖DKD的定义、筛查、诊断、分期、评估及防治。突出早期筛查,强调规范化综合管理的重要性,注重新型抗高血糖药物在DKD治疗中的作用;强调"诊断-分期-评估-防治"的一体化诊疗模式,并制定诊疗流程图,突出临床实用性。威廉亚洲博彩公司 将有助于临床医师对DKD患者进行规范化管理,并致力于改善DKD患者的预后。 
 

相关资料下载：
[AttachmentFileName(sort=1, fileName=中国糖尿病肾脏病防治威廉亚洲博彩公司 （2021年版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1f36f1c0021958af, title=中国糖尿病肾脏病防治威廉亚洲博彩公司 (2021年版), enTitle=, guiderFrom=国际内分泌代谢杂志. 2021,41(04), authorId=0, author=, summary=近年来,国内外糖尿病肾脏病（DKD）的研究取得了许多重要进展,获得了更多循证医学证据。中华医学会糖尿病学分会微血管并发症学组组织全国内分泌及肾脏病领域相关专家编写了该威廉亚洲博彩公司 ,旨在传递最新及重要进展,进一, cover=https://img.medsci.cn/2021929/1632847551648_2020535.jpg, journalId=0, articlesId=null, associationId=88, associationName=中华医学会糖尿病学分会, associationIntro=中华医学会糖尿病学分会（Chinese Diabetes Society）是中华医学会的直属专业学会，使命是：通过教育、研究和医疗来预防、治疗和根除糖尿病（Prevention, care and cure diabetes through education, research and good medical practice.）。, copyright=0, guiderPublishedTime=Tue Jul 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">近年来,国内外糖尿病肾脏病（DKD）的研究取得了许多重要进展,获得了更多循证医学证据。中华医学会糖尿病学分会微血管并发症学组组织全国内分泌及肾脏病领域相关专家编写了该威廉亚洲博彩公司 ,旨在传递最新及重要进展,进一步规范DKD的管理。威廉亚洲博彩公司 内容涵盖DKD的定义、筛查、诊断、分期、评估及防治。突出早期筛查,强调规范化综合管理的重要性,注重新型抗高血糖药物在DKD治疗中的作用;强调"诊断-分期-评估-防治"的一体化诊疗模式,并制定诊疗流程图,突出临床实用性。威廉亚洲博彩公司 将有助于临床医师对DKD患者进行规范化管理,并致力于改善DKD患者的预后。&nbsp;</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=83808, tagName=糖尿病肾脏病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=83808, guiderKeyword=糖尿病肾脏病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=74153, appHits=1326, showAppHits=0, pcHits=2496, showPcHits=72816, likes=7, shares=172, comments=51, approvalStatus=1, publishedTime=Wed Sep 29 00:47:26 CST 2021, publishedTimeString=2021-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 29 00:46:07 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:13:57 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国糖尿病肾脏病防治威廉亚洲博彩公司 （2021年版）.pdf)])
中国糖尿病肾脏病防治威廉亚洲博彩公司 （2021年版）.pdf
下载请点击：
评论区 (42)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2173352, encodeId=1e9821e335278, content=学习了新的进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6ad9097745, createdName=ms6000000772885314, createdTime=Wed Dec 06 20:33:33 CST 2023, time=2023-12-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170067, encodeId=4cee21e00679e, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36e5427322, createdName=ms2000000651872675, createdTime=Tue Nov 21 20:42:56 CST 2023, time=2023-11-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1218591, encodeId=7cd612185910e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:18:46 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202828, encodeId=e22c1202828f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:20 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199667, encodeId=7ee5119966ee2, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25b86536732, createdName=ms3000001121207922, createdTime=Sat Mar 05 15:32:57 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2023-12-06 ms6000000772885314 来自湖北省

    学习了新的进展

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2173352, encodeId=1e9821e335278, content=学习了新的进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6ad9097745, createdName=ms6000000772885314, createdTime=Wed Dec 06 20:33:33 CST 2023, time=2023-12-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170067, encodeId=4cee21e00679e, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36e5427322, createdName=ms2000000651872675, createdTime=Tue Nov 21 20:42:56 CST 2023, time=2023-11-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1218591, encodeId=7cd612185910e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:18:46 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202828, encodeId=e22c1202828f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:20 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199667, encodeId=7ee5119966ee2, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25b86536732, createdName=ms3000001121207922, createdTime=Sat Mar 05 15:32:57 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2023-11-21 ms2000000651872675 来自湖南省

    学习啦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2173352, encodeId=1e9821e335278, content=学习了新的进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6ad9097745, createdName=ms6000000772885314, createdTime=Wed Dec 06 20:33:33 CST 2023, time=2023-12-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170067, encodeId=4cee21e00679e, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36e5427322, createdName=ms2000000651872675, createdTime=Tue Nov 21 20:42:56 CST 2023, time=2023-11-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1218591, encodeId=7cd612185910e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:18:46 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202828, encodeId=e22c1202828f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:20 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199667, encodeId=7ee5119966ee2, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25b86536732, createdName=ms3000001121207922, createdTime=Sat Mar 05 15:32:57 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2022-05-10 ms9000000231852747

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2173352, encodeId=1e9821e335278, content=学习了新的进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6ad9097745, createdName=ms6000000772885314, createdTime=Wed Dec 06 20:33:33 CST 2023, time=2023-12-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170067, encodeId=4cee21e00679e, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36e5427322, createdName=ms2000000651872675, createdTime=Tue Nov 21 20:42:56 CST 2023, time=2023-11-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1218591, encodeId=7cd612185910e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:18:46 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202828, encodeId=e22c1202828f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:20 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199667, encodeId=7ee5119966ee2, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25b86536732, createdName=ms3000001121207922, createdTime=Sat Mar 05 15:32:57 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2022-03-15 董彦钦

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2173352, encodeId=1e9821e335278, content=学习了新的进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6ad9097745, createdName=ms6000000772885314, createdTime=Wed Dec 06 20:33:33 CST 2023, time=2023-12-06, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170067, encodeId=4cee21e00679e, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f36e5427322, createdName=ms2000000651872675, createdTime=Tue Nov 21 20:42:56 CST 2023, time=2023-11-21, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=1218591, encodeId=7cd612185910e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10658139247, createdName=ms9000000231852747, createdTime=Tue May 10 22:18:46 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202828, encodeId=e22c1202828f6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bd04833195, createdName=董彦钦, createdTime=Tue Mar 15 18:48:20 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199667, encodeId=7ee5119966ee2, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25b86536732, createdName=ms3000001121207922, createdTime=Sat Mar 05 15:32:57 CST 2022, time=2022-03-05, status=1, ipAttribution=)]
    2022-03-05 ms3000001121207922

    赞

    0

以上为热门评论，williamhill asia 医学App还有更多内容

相关威廉亚洲博彩公司

糖尿病肾脏疾病早期预测与诊断专家共识

暂未更新 · 2021-06-15

拓展阅读

糖尿病肾脏疾病早期预测与诊断专家共识

暂未更新 · 2021-06-15

中国糖尿病肾脏病防治威廉亚洲博彩公司 （2021年版）解读

应急总医院内分泌科 · 2022-02-01

《中国糖尿病肾脏病防治威廉亚洲博彩公司 》（2021年版）解读

南方医科大学南方医院内分泌代谢科 · 2022-05-15

中成药治疗糖尿病肾脏病临床应用专家共识

天津中医药大学第一附属医院内分泌科 · 2022-07-12

中成药治疗糖尿病肾脏病临床应用专家共识威廉亚洲博彩公司 解读

陕西省中医医院 · 2022-11-21